drugset

drugset / Trial / NCT01439828

Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal

NCT01439828 ↗

Phase 2 Terminated 6 enrolled Assistance Publique - Hôpitaux de Paris

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose is to assess the efficacy in human of N-acetylcysteine versus placebo during 4 weeks in cannabis withdrawal.

Timeline

Start: 2012-02
Primary completion: 2012-02
Completion: 2015-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	N-acetylcystein	Unknown	800 mg	—

Indications